HCA Healthcare Inc (HCA)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:HCA Healthcare Inc (HCA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014194
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:90
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HCA Healthcare Inc (HCA), formerly known as HCA Holdings Inc, is a health care services company that provides a wide range of services in specialties including internal medicine; general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics. It also offers outpatient and ancillary health care services; diagnostic and emergency services and mental health care services. The company operates a network of hospitals; freestanding surgery centers and emergency care facilities; diagnostic and imaging centers; radiation and oncology therapy centers; comprehensive rehabilitation and physical therapy centers; and various other facilities. HCA operates its facilities in various states of the US and in England, the UK. HCA is headquartered in Nashville, Tennessee, the US.

HCA Healthcare Inc (HCA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
HCA Healthcare Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
HCA Healthcare Inc, Medical Devices Deals, 2011 to YTD 2017 9
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
TriStar Health System To Acquire Grandview Medical Center From Capella Healthcare 12
HCA Completes Acquisition Of Galichia Heart Hospital 13
HCA Completes Acquisition Of Mercy Hospital From Mercy Health Partners 14
Partnerships 15
HCA Enters into Research Agreement with Harvard Pilgrim Health Care 15
National HealthCare Enters Into Joint Venture Agreement With TriStar Health System 16
TriStar Health System Enters Into Joint Venture Agreement With CareSpot 17
Equity Offering 18
HCA Completes IPO For US$2.6 Billion 18
Debt Offering 21
HCA Prices Public Offering of 5.375% Notes Due 2025 for USD1.6 Billion 21
HCA Prices Public Offering of 4.25% Notes Due 2019 for USD600 Million 23
HCA Prices Public Offering of 5.25% Notes Due 2025 for USD1.4 Billion 25
HCA Raises USD2 Billion in Public Offering of 5% Notes Due 2024 27
HCA Raises USD1.5 Billion in Public Offering of 3.75% Notes Due 2019 29
HCA Completes Public Offering Of Notes Due 2021 For US$1 Billion 31
HCA Holdings Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 33
HCA Holdings Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 35
HCA Completes Public Offering Of Notes Due 2022 For US$1.35 Billion 37
HCA Plans Public Offering of Notes For US$500 Million 39
HCA Completes Public Offering Of Senior Unsecured Notes Due 2018 For US$500 Million 40
HCA Holdings Completes Public Offering Of Senior Secured Notes Due 2020 For US$3,000 Million 42
HCA Completes Public Offering Of Senior Unsecured Notes Due 2022 For US$2,000 Million 44
Asset Transactions 46
Hospital Authority of Albany Acquires Palmyra Medical Center From HCA For US$198 Million 46
Emory Healthcare Acquires Remaining Stake In Emory Johns Creek Hospital From HCA 47
Acquisition 48
HCA Holdings to Acquire CareNow 48
HCA Holdings Rumored To Bid For Healthscope For US$4.5 Billion 49
Parallon Business Solutions Completes Acquisition Of The Outsource Group From ClearLight Partners 51
TriStar Health System And CareSpot Acquire NeighborMD 53
Citrus Memorial Health System Plans To Sell Itself 54
HCA Acquires 40% Stake In HCA-HealthONE From Colorado Health For US$1,450 Million 55
HCA Healthcare Inc – Key Competitors 57
HCA Healthcare Inc – Key Employees 58
HCA Healthcare Inc – Locations And Subsidiaries 60
Head Office 60
Other Locations & Subsidiaries 60
Joint Venture 62
Recent Developments 64
Financial Announcements 64
Oct 31, 2017: HCA Reports Third Quarter 2017 Results 64
Oct 18, 2017: HCA Previews 2017 Third Quarter Results 67
Jul 25, 2017: HCA Reports Second Quarter 2017 Results 69
May 02, 2017: HCA Reports First Quarter 2017 Results 71
Apr 17, 2017: HCA Previews 2017 First Quarter Results 72
Jan 31, 2017: HCA Reports Fourth Quarter 2016 Results 73
Oct 27, 2016: HCA Reports Third Quarter 2016 Results 75
Jul 28, 2016: HCA Reports Second Quarter 2016 Results 77
May 03, 2016: HCA Reports First Quarter 2016 Results 79
Jan 28, 2016: HCA Reports Fourth Quarter 2015 Results 81
Corporate Communications 83
Nov 14, 2017: Peyton Elliott Named CEO of Park Plaza Hospital 83
Sep 01, 2017: Ashley Johnson Appointed Chief Financial Officer of HCA Healthcare’s American Group 84
Aug 29, 2017: HCA Healthcare Gives up to $2 Million for Hurricane Relief in Texas 85
Jul 25, 2016: Heather Rohan to Be Appointed President of HCA’s TriStar Division 86
Jul 08, 2016: Tim McManus Appointed President of HCA’s Capital Division 87
May 06, 2016: Troy A. Villarreal Appointed President of HCA’s Gulf Coast Division 88
Apr 28, 2016: HCA Announces Charles O. Holliday, Jr. Elected as New Independent Director 89
Appendix 90
Methodology 90
About GlobalData 90
Contact Us 90
Disclaimer 90

List of Tables
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
HCA Healthcare Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
HCA Healthcare Inc, Medical Devices Deals, 2011 to YTD 2017 9
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
TriStar Health System To Acquire Grandview Medical Center From Capella Healthcare 12
HCA Completes Acquisition Of Galichia Heart Hospital 13
HCA Completes Acquisition Of Mercy Hospital From Mercy Health Partners 14
HCA Enters into Research Agreement with Harvard Pilgrim Health Care 15
National HealthCare Enters Into Joint Venture Agreement With TriStar Health System 16
TriStar Health System Enters Into Joint Venture Agreement With CareSpot 17
HCA Completes IPO For US$2.6 Billion 18
HCA Prices Public Offering of 5.375% Notes Due 2025 for USD1.6 Billion 21
HCA Prices Public Offering of 4.25% Notes Due 2019 for USD600 Million 23
HCA Prices Public Offering of 5.25% Notes Due 2025 for USD1.4 Billion 25
HCA Raises USD2 Billion in Public Offering of 5% Notes Due 2024 27
HCA Raises USD1.5 Billion in Public Offering of 3.75% Notes Due 2019 29
HCA Completes Public Offering Of Notes Due 2021 For US$1 Billion 31
HCA Holdings Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 33
HCA Holdings Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 35
HCA Completes Public Offering Of Notes Due 2022 For US$1.35 Billion 37
HCA Plans Public Offering of Notes For US$500 Million 39
HCA Completes Public Offering Of Senior Unsecured Notes Due 2018 For US$500 Million 40
HCA Holdings Completes Public Offering Of Senior Secured Notes Due 2020 For US$3,000 Million 42
HCA Completes Public Offering Of Senior Unsecured Notes Due 2022 For US$2,000 Million 44
Hospital Authority of Albany Acquires Palmyra Medical Center From HCA For US$198 Million 46
Emory Healthcare Acquires Remaining Stake In Emory Johns Creek Hospital From HCA 47
HCA Holdings to Acquire CareNow 48
HCA Holdings Rumored To Bid For Healthscope For US$4.5 Billion 49
Parallon Business Solutions Completes Acquisition Of The Outsource Group From ClearLight Partners 51
TriStar Health System And CareSpot Acquire NeighborMD 53
Citrus Memorial Health System Plans To Sell Itself 54
HCA Acquires 40% Stake In HCA-HealthONE From Colorado Health For US$1,450 Million 55
HCA Healthcare Inc, Key Competitors 57
HCA Healthcare Inc, Key Employees 58
HCA Healthcare Inc, Other Locations 60
HCA Healthcare Inc, Subsidiaries 61
HCA Healthcare Inc, Joint Venture 62

★海外企業調査レポート[HCA Healthcare Inc (HCA)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pakistan State Oil Co Ltd (PSO):企業の財務・戦略的SWOT分析
    Pakistan State Oil Co Ltd (PSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • BowLeven plc (BLVN):企業の財務・戦略的SWOT分析
    Summary BowLeven Plc (BowLeven) is an independent oil and gas exploration and production company. The company’s business activities include acquisition, exploration, and development of oil and gas properties. It holds equity interests in offshore and onshore exploration acreage in Cameroon and Gabon …
  • GW Pharmaceuticals Plc (GWPH):医療機器:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • Ballard Power Systems Inc (BLDP):電力:M&Aディール及び事業提携情報
    Summary Ballard Power Systems Inc (Ballard Power) is a clean energy growth company. It designs, develops, manufactures, sells, and services proton exchange membrane (PEM) fuel cell products for power product markets, portable power, and material handling and backup power. The company’s product lines …
  • Ophthotech Corp (OPHT):製薬・医療:M&Aディール及び事業提携情報
    Summary Ophthotech Corp (Ophthotech) is a biopharmaceutical company that offers novel therapeutics to treat diseases of the back of the eye for age-related macular degeneration. The company’s products include Zimura, an anti-complemente is a central component of the complement cascade that is suppos …
  • Berkshire Hathaway Inc:企業の戦略・SWOT・財務分析
    Berkshire Hathaway Inc - Strategy, SWOT and Corporate Finance Report Summary Berkshire Hathaway Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • UNeMed Corp-医療機器分野:企業M&A・提携分析
    Summary UNeMed Corp (UneMed), a subsidiary of University of Nebraska Medical Center is a healthcare service provider that offers technology transfer and commercialization services. The company offers services such as inventions, material transfer, confidentiality, intellectual property, startup form …
  • Taikisha Ltd:企業の戦略・SWOT・財務分析
    Taikisha Ltd - Strategy, SWOT and Corporate Finance Report Summary Taikisha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Qingdao Haier Co., Ltd. (600690):企業の財務・戦略的SWOT分析
    Qingdao Haier Co., Ltd. (600690) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • China Sunergy Co., Ltd.:企業の戦略的SWOT分析
    China Sunergy Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Moravske naftove doly AS:企業の戦略的SWOT分析
    Moravske naftove doly AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Gordon Food Service:戦略・SWOT・企業財務分析
    Gordon Food Service - Strategy, SWOT and Corporate Finance Report Summary Gordon Food Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Abbott Diagnostics:企業の製品パイプライン分析2018
    Summary Abbott Diagnostics, a subsidiary of Abbott Laboratories, is a manufacturer of in vitro diagnostic systems and tests. The company offers core laboratory products, molecular point of care products, transfusion medicine, professional services and diagnostics portfolio. Its products include labo …
  • El Al Israel Airlines Ltd.:戦略・SWOT・企業財務分析
    El Al Israel Airlines Ltd. - Strategy, SWOT and Corporate Finance Report Summary El Al Israel Airlines Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Sanofi (SAN):企業の財務・戦略的SWOT分析
    Sanofi (SAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Banco Pan SA (BPAN4):企業の財務・戦略的SWOT分析
    Banco Pan SA (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ahli Bank Qsc
    Ahli Bank Qsc - Strategy, SWOT and Corporate Finance Report Summary Ahli Bank Qsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Shanghai Shyndec Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Shanghai Shyndec Pharmaceutical Co Ltd (Shanghai Shyndec) a subsidiary of China National Pharmaceutical Group Corp, is a pharmaceutical company which focuses on the production and sale of active pharmaceutical ingredients (API’s), oral preparations and finished drugs. Its product portfolio i …
  • NxStage Medical Inc (NXTM):企業の財務・戦略的SWOT分析
    NxStage Medical Inc (NXTM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Henry Schein Inc (HSIC):企業の財務・戦略的SWOT分析
    Henry Schein Inc (HSIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆